Abstract
The emergence of H5N1 clade 2.3.4.4b in dairy cattle raised concerns over the safety of fluid milk. We developed two stochastic quantitative risk assessment models to represent the United States raw and pasteurized fluid milk supply chains and employed these models in baseline, sensitivity, and scenario analysis. Median (5th, 95th percentiles) probabilities of infection per 240-mL pasteurized and farmstore-purchased raw milk serving were 5.68E-15 (1.766E-16, 2.98E-13) and 1.13E-03 (5.16E-06, 3.82E-02), respectively. This metric was highly sensitive to the viral titers in infected cows’ milk. Pasteurization is highly effective at reducing this risk. Bulk tank milk PCR testing is more effective at reducing the probability of infection per raw milk serving than improving the identification and diversion of infected cows’ milk at harvest. These findings emphasize the importance of pasteurization and dairy cow disease surveillance in reducing the risk of H5N1 infection associated with fluid milk consumption.
Summary In this epidemiologic study, the public health risk of human H5N1 infection from drinking raw and pasteurized milk is investigated by use of quantitative risk assessment models.
Biosketch Katherine J. Koebel earned her Bachelor’s in Animal Science from Michigan State University and her Doctor of Veterinary Medicine from Cornell University. Her research draws from skills and experience in quantitative analysis, epidemiologic modeling, and dairy science. She is currently a PhD student in Epidemiology at Cornell University, researching One Health in the context of dairy cattle population medicine.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
Research reported in this publication was supported by the Office of the Director, National Institutes of Health of the National Institutions of Health (NIH) under Award Number T32ODO011000. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Center for Research Resources or the NIH. Additionally, this research was partially supported by grants to RI from the National Institute of Food and Agriculture, USDA, Hatch under Accession Number 7000433, as well as Multistate Research Funds Accession Number 1016738.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in this work are available upon reasonable request to the corresponding author.
